Heart Failure Evaluation (ID: i749) Survey

Question Title

* 1. How many patients with or at risk for developing heart failure do you currently manage in your practice? Please respond with your best approximate number.

1 to 10

11 to 25

26 to 50

I am not directly involved in patient care

Question Title

* 2. Of the patients you will see in the next week, about how many will benefit from the information you learned today?

1 to 10

11 to 25

26 to 50

I am not directly involved in patient care

Question Title

* 3. How many years have you been in practice?

1-10

11-20

> 21

Question Title

* 4. Which new strategies/skills/information will you apply to your area of practice? Please select all that apply.

Implement a multidisciplinary approach

Apply recent findings regarding FDA-approved therapies for HF

Consider safety and efficacy data of emerging therapies in treatment selection

Assess patient burdens associated with HF

Employ patient-centered care

Question Title

* 5. Which of the following best describes the impact of this activity on your performance?

I gained new strategies/skills/information that I can apply to my area of practice

I need more information before I change my practice behavior

This activity will not change my practice, as my current practice is consistent with the information presented

This activity will not change my practice, as I do not agree with the information presented

Question Title

* 6. How committed are you to making changes in your practice based on your participation in this activity?

Very committed

Committed

Neutral

Not committed

I do not plan to make changes

Question Title

* 7. After participating in this activity, I am now able to:

	Strongly agree	Agree	Neutral	Disagree	Strongly disagree
Examine the differences between heart failure with reduced ejection fraction (HFrEF), heart failure with mid-range ejection fraction (HFmEF), and heart failure with preserved ejection fraction (HFpEF)	Examine the differences between heart failure with reduced ejection fraction (HFrEF), heart failure with mid-range ejection fraction (HFmEF), and heart failure with preserved ejection fraction (HFpEF) Strongly agree	Examine the differences between heart failure with reduced ejection fraction (HFrEF), heart failure with mid-range ejection fraction (HFmEF), and heart failure with preserved ejection fraction (HFpEF) Agree	Examine the differences between heart failure with reduced ejection fraction (HFrEF), heart failure with mid-range ejection fraction (HFmEF), and heart failure with preserved ejection fraction (HFpEF) Neutral	Examine the differences between heart failure with reduced ejection fraction (HFrEF), heart failure with mid-range ejection fraction (HFmEF), and heart failure with preserved ejection fraction (HFpEF) Disagree	Examine the differences between heart failure with reduced ejection fraction (HFrEF), heart failure with mid-range ejection fraction (HFmEF), and heart failure with preserved ejection fraction (HFpEF) Strongly disagree
Incorporate guideline recommendations and recent clinical trial data in the management of special populations including older adults and African-Americans as well as HF patients who may overlapping comorbidities such as diabetes and renal insufficiency	Incorporate guideline recommendations and recent clinical trial data in the management of special populations including older adults and African-Americans as well as HF patients who may overlapping comorbidities such as diabetes and renal insufficiency Strongly agree	Incorporate guideline recommendations and recent clinical trial data in the management of special populations including older adults and African-Americans as well as HF patients who may overlapping comorbidities such as diabetes and renal insufficiency Agree	Incorporate guideline recommendations and recent clinical trial data in the management of special populations including older adults and African-Americans as well as HF patients who may overlapping comorbidities such as diabetes and renal insufficiency Neutral	Incorporate guideline recommendations and recent clinical trial data in the management of special populations including older adults and African-Americans as well as HF patients who may overlapping comorbidities such as diabetes and renal insufficiency Disagree	Incorporate guideline recommendations and recent clinical trial data in the management of special populations including older adults and African-Americans as well as HF patients who may overlapping comorbidities such as diabetes and renal insufficiency Strongly disagree
Articulate the importance of multidisciplinary care for special populations of patients with HF	Articulate the importance of multidisciplinary care for special populations of patients with HF Strongly agree	Articulate the importance of multidisciplinary care for special populations of patients with HF Agree	Articulate the importance of multidisciplinary care for special populations of patients with HF Neutral	Articulate the importance of multidisciplinary care for special populations of patients with HF Disagree	Articulate the importance of multidisciplinary care for special populations of patients with HF Strongly disagree

Question Title

* 8. The content presented:

	Strongly agree	Agree	Neutral	Disagree	Strongly disagree
Enhanced my current knowledge base	Enhanced my current knowledge base Strongly agree	Enhanced my current knowledge base Agree	Enhanced my current knowledge base Neutral	Enhanced my current knowledge base Disagree	Enhanced my current knowledge base Strongly disagree
Addressed my most pressing questions	Addressed my most pressing questions Strongly agree	Addressed my most pressing questions Agree	Addressed my most pressing questions Neutral	Addressed my most pressing questions Disagree	Addressed my most pressing questions Strongly disagree
Promoted improvements or quality in health care	Promoted improvements or quality in health care Strongly agree	Promoted improvements or quality in health care Agree	Promoted improvements or quality in health care Neutral	Promoted improvements or quality in health care Disagree	Promoted improvements or quality in health care Strongly disagree
Was scientifically rigorous and evidence based	Was scientifically rigorous and evidence based Strongly agree	Was scientifically rigorous and evidence based Agree	Was scientifically rigorous and evidence based Neutral	Was scientifically rigorous and evidence based Disagree	Was scientifically rigorous and evidence based Strongly disagree
Avoided commercial bias or influence	Avoided commercial bias or influence Strongly agree	Avoided commercial bias or influence Agree	Avoided commercial bias or influence Neutral	Avoided commercial bias or influence Disagree	Avoided commercial bias or influence Strongly disagree

Question Title

* 9. As a result of your participation in this activity, which of the following changes are you most likely to implement in your practice? Please select all that apply.

Incorporate guideline recommendations and recent clinical trial data as appropriate for the management of special populations of patients including older adults, African-Americans, patients with T2D, and those with renal insufficiency

Implement multidisciplinary care for special populations of patients with HF

Other changes you plan to make (please explain)

I don’t plan make any changes to my practice based on the activity (please explain)

please explain

Question Title

* 10. How would you rate the format of this activity?

Excellent

Good

Average

Poor

Question Title

* 11. What barriers do you see to making changes in your practice?

Question Title

* 12. Please list any clinical issues/problems within your scope of practice you would like to see addressed in future educational activities in regards to Heart Failure diagnosis and management:

Question Title

* 1. How many patients with or at risk for developing heart failure do you currently manage in your practice? Please respond with your best approximate number.

Question Title

* 2. Of the patients you will see in the next week, about how many will benefit from the information you learned today?

Question Title

* 3. How many years have you been in practice?

Question Title

* 4. Which new strategies/skills/information will you apply to your area of practice? Please select all that apply.

Question Title

* 5. Which of the following best describes the impact of this activity on your performance?

Question Title

* 6. How committed are you to making changes in your practice based on your participation in this activity?

Question Title

* 7. After participating in this activity, I am now able to:

Question Title

* 8. The content presented:

Question Title

* 9. As a result of your participation in this activity, which of the following changes are you most likely to implement in your practice? Please select all that apply.

Question Title

* 10. How would you rate the format of this activity?

Question Title

* 11. What barriers do you see to making changes in your practice?

Question Title

* 12. Please list any clinical issues/problems within your scope of practice you would like to see addressed in future educational activities in regards to Heart Failure diagnosis and management:

Question Title

* 13. If you indicated that you perceived commercial bias or influence, please describe: